Injective has partnered with South Korean custodian BDACS to integrate the KRW1 stablecoin, backed by the Korean won and held in escrow at Woori Bank, into its blockchain network. This allows KRW1 to be traded and settled within Injective's real-world asset ecosystem, linking traditional fiat currency with blockchain infrastructure for institutional users. The KRW1 token, which has a current on-chain supply of about 13.67 million, aims to reduce foreign exchange risks for Korean institutions and expand non-dollar settlement options. The partnership could boost KRW1 adoption if more trading venues and asset issuers choose to use the won for pricing and settlement.
Injective's new KRW1 stablecoin partnership is noted here with Pluang's market data as of Oct 20, 2026 20:51 WIB. For readers following major cryptocurrencies, 23 of 50 rose and 25 fell today. Notable movers include XTZ at Rp5.526 with a 2.37% increase and 100% buy order activity, FTM at Rp11.382 down 2.05%, and COTI at Rp197 up 1.79%.
Synchrony Financial reported Q3 2026 earnings per share of $2.68 and revenue of $4.91 billion, both exceeding analyst expectations. However, net profit fell to $892 million from $1.1 billion the previous year due to higher operating costs, even as cr...
Hancock Whitney is set to report its Q3 2026 earnings on October 20, with analysts forecasting earnings per share between $1.65 and $1.66 and revenue estimates from $418.85 million to $422 million. Despite year-over-year growth projections, indicator...
In September 2026, New York State's housing inventory increased by 9.8% year-over-year, reaching 35,294 homes available for sale. Despite this rise in supply, home prices continued to grow, with the median sales price up 5.9% to $450,000 compared to ...
The Europe Electronic Health Record (EHR) market is projected to grow from $8.05 billion in 2024 to $15.37 billion by 2031, at a compound annual growth rate of 9.9%. Growth is fueled by increasing EHR adoption, government digital health programs, and...
EssilorLuxottica reported a 9.0% increase in revenue for Q3 2026, reaching €7,486 million, with a 7.2% rise at constant exchange rates. Growth was broad-based, with strong double-digit increases in Asia-Pacific and the Direct to Consumer segment up 1...
